Trial intelligence / Profile preview

Low-dose dasatinib 50 mg first-line treatment in newly diagnosed chronic-phase CML

ChiCTR2200060751Phase 4Not yet recruiting

Sponsor

Union Hospital

Start

Jun 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1